Skip to main content

Patent Expiry

EBS: TEMBEXA: recorded patent 10112909 expiry

October 10, 2034 · BRINCIDOFOVIR. BioSniper AI can trace the company-impact path without requiring you to write the research question.

Event date
October 10, 2034
Company
Emergent BioSolutions Inc. (EBS)
Drug
BRINCIDOFOVIR
BioSniper AIPage evidence connected

Prepared research question

What could this event change, and which evidence should be watched next?

Run cited research

Traceable citations · Unknowns marked

Patent Expiry

TEMBEXA: recorded patent 10112909 expiry

Orange Book application NDA214461, product 001, listed patent 10112909 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source

Drug
BRINCIDOFOVIR